Literature DB >> 6303950

Protective immunization of mice with specific HSV-1 glycoproteins.

W L Chan.   

Abstract

Two herpes simplex virus type 1 (HSV-1) antigens of apparent molecular weight 123,000 and 63,000 which are associated with the viral glycoprotein complex have been identified and purified using virus-specific monoclonal antibodies. Mice immunized with either glycoprotein showed marked resistance to challenge with virulent HSV-1. Therefore purified glycoproteins of HSV-1 free of nucleic acid can be used in protective immunization of mice against human herpes simplex type 1.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6303950      PMCID： PMC1454196     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

2.  Genetic and biochemical studies with herpesvirus.

Authors:  J H Subak-Sharpe; S M Brown; D A Ritchie; M C Timbury; J C Macnab; H S Marsden; J Hay
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Genetics of natural resistance to herpesvirus infections in mice.

Authors:  C Lopez
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

4.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

5.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

6.  Immunological destruction of herpes simplex virus I infected cells.

Authors:  B Rager-Zisman; B R Bloom
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

7.  Spread of herpes simplex virus in peripheral nerves.

Authors:  K Kristensson; E Lycke; J Sjöstrand
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

8.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422
View more
  40 in total

1.  Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis.

Authors:  G R Skinner; C Fink; J Melling; C Wiblin; B Thornton; J Hallworth; W Gardner; P McLeish; C Hartley; A Buchan
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

2.  Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells.

Authors:  C C Marchioli; R J Yancey; E A Petrovskis; J G Timmins; L E Post
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein.

Authors:  D L Sodora; G H Cohen; M I Muggeridge; R J Eisenberg
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 4.  New aspects of vaccine development.

Authors:  F Y Liew
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.

Authors:  G Kümel; H C Kaerner; M Levine; C H Schröder; J C Glorioso
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.

Authors:  S D Marlin; S L Highlander; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

7.  Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.

Authors:  G H Cohen; V J Isola; J Kuhns; P W Berman; R J Eisenberg
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

8.  Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.

Authors:  S Welling-Wester; M Feijlbrief; D G Koedijk; J W Drijfhout; W J Weijer; A J Scheffer; G W Welling
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity.

Authors:  W L Chan; M L Tizard; L Faulkner
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

10.  Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.

Authors:  J Glorioso; C H Schröder; G Kumel; M Szczesiul; M Levine
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.